British American Tobacco (BATS) 21st Annual dbAccess Global Consumer Conference 2024 summary
Event summary combining transcript, slides, and related documents.
21st Annual dbAccess Global Consumer Conference 2024 summary
31 Jan, 2026Strategic transformation and smokeless ambition
Targeting over 50% of revenue from smokeless products by 2035, leveraging a multi-category strategy and targeted investments.
Focused on quality growth, balancing top-line expansion in new categories with margin improvement and disciplined resource allocation.
Expanding into adjacent categories, including cannabis and wellbeing, as part of a long-term diversification plan.
Building a collaborative, inclusive culture with revised company values and transparent communication, fostering innovation.
Ongoing transformation towards a smokeless world remains a core objective.
Financial performance and guidance
On track to deliver low single-digit revenue and profit growth for 2024, with stronger performance expected in H2 due to inventory normalization and innovation rollouts.
Achieved breakeven in new categories two years ahead of target, with ongoing improvements in gross and operating margins.
Announced share buybacks of £700m in 2024 and £900m in 2025, supported by strong cash generation and partial monetization of ITC stake.
Revised leverage target to 2x-2.5x by end of 2024, aiming for further progress ex-Canada by 2026.
Multi-year guidance targets 3%-5% revenue growth and mid-single-digit operating profit growth by 2026.
U.S. market and brand performance
Stabilized U.S. market share and grew premium share through targeted interventions in Newport and Natural American Spirit.
Implemented price laddering and data-driven revenue management to retain consumers and enhance brand resilience.
Lucky Strike is the fastest-growing cigarette brand in the U.S., with increased sales force and analytics investment.
Addressing challenges from illegal vapor products, expecting enforcement improvements in 2025 to support legal market share.
Consumer confidence is gradually recovering, with expectations of further improvement as macroeconomic conditions ease.
Latest events from British American Tobacco
- Accelerating smokeless transformation and U.S. growth through innovation and regulatory action.BATS
Consumer Analyst Group of New York Conference (CAGNY) 202619 Feb 2026 - 2025 results hit top guidance, led by Modern Oral growth and strong U.S. and AME performance.BATS
H2 202512 Feb 2026 - New Category growth and innovation offset U.S. headwinds, supporting full-year guidance.BATS
H1 20243 Feb 2026 - Guidance reaffirmed as new categories and innovation drive H2 acceleration and cash returns.BATS
Trading Update31 Jan 2026 - Accelerates smokeless transformation, targeting >50% revenue from new categories by 2035.BATS
CMD 202419 Jan 2026 - On track for guidance with innovation, new category growth, and strong cash generation.BATS
Trading Update11 Jan 2026 - New category growth and cost discipline offset regulatory and illicit trade headwinds in 2024.BATS
H2 20248 Jan 2026 - FY25 outlook reaffirmed with growth, strong U.S. momentum, and a £1.3bn FY26 share buy-back.BATS
Trading Update9 Dec 2025 - FY25 outlook raised as U.S. and Modern Oral growth offset regulatory headwinds.BATS
Trading Update18 Nov 2025